Related Experiment Video

Updated: Nov 16, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

1.5K

Hematopoietic Stem Cell Transplantation for Children With Inborn Errors of Immunity

Geeta M Gonvindaraj1, U Ramya2, T P Ashraf3

  • 1Department of Pediatrics, Government Medical College, Kozhikode, Kerala, India. geetakkumar@gmail.com.

Indian Pediatrics
|February 26, 2021
PubMed

Insights

Children with inborn errors of immunity often face delayed diagnosis and treatment. Early detection through newborn screening and expanded donor registries are crucial for timely hematopoietic stem cell transplant (HSCT).

Area of Science:

  • Pediatrics
  • Immunology
  • Hematology

Background:

  • Inborn errors of immunity (IEI) are a group of rare genetic disorders affecting the immune system.
  • Hematopoietic stem cell transplant (HSCT) is a potentially curative treatment for severe IEI.
  • Timely diagnosis and treatment are critical for improving outcomes in children with IEI.

Purpose of the Study:

  • To analyze the clinical characteristics of children with IEI who received HSCT.
  • To identify delays in diagnosis and treatment for children with IEI.
  • To highlight the need for improved awareness and screening for IEI.

Main Methods:

  • Retrospective analysis of clinical data.
  • Review of patient records for children with IEI undergoing HSCT.
  • Analysis of age at diagnosis and age at HSCT.

Main Results:

  • The mean age at diagnosis for children with IEI was 24.4 months.
  • The mean age at HSCT was significantly later, at 51.9 months.
  • This indicates a substantial delay between diagnosis and treatment.

Conclusions:

  • There are significant delays in the diagnosis and treatment of children with IEI.
  • Improved awareness of IEI among healthcare professionals is needed.
  • Expanding donor registries and implementing newborn screening for IEI are essential to facilitate earlier HSCT and improve patient outcomes.

More Related Videos

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.0K
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

685

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
636
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.6K